Are Your Patients Running Out of Supplies for Their Continuous Glucose Monitor?
Pharmacies often struggle with audits for DMEPOS items. The Medicare Part B/DMEPOS billing model is a complex maze of units, codes and documentation requirements that are very different from billing traditional prescription drugs. This model produces high error rates and recoupments across the country. You must have a strong understanding of these differences to prevent audit recoupment. This article discusses how to bill supplies for Continuous Glucose Monitors (CGMs).
- Continuous Glucose Monitors and Potential Audit Risk with PHE Ending - May 26, 2023
- Avoiding Humana Audits for Deceased Patients - May 9, 2023
- A Documentation Checklist for Continuous Glucose Monitor Claims - April 15, 2023